Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Each additional chronic condition among older people diminishes life expectancy.
The FDA has approved Striverdi Respimat (olodaterol; Boehringer Ingelheim) inhalation spray for the treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema with airflow obstruction.
Medical costs for chronic obstructive pulmonary disease (COPD) in the United States are more than $32 billion each year, according to new research from the CDC.
For children with obstructive sleep apnea syndrome (OSAS), early adenotonsillectomy (eAT) is associated with greater weight gain.
This activity provides in-depth guidance for the pharmacologic and nonpharmacologic treatment of arthritis, and management ...
This activity will explain different ways to treat patients suffering from COPD using medications and ...